Millennium Post (Kolkata)

IMPCL achieves highest-ever turnover of `160 cr


NEW DELHI: With its products attracting more buyers, Indian Medicines Pharmaceut­ical Corporatio­n Limited (IMPCL), the public sector manufactur­ing unit of the Ministry of AYUSH, has recorded its highest-ever turnover of Rs 164 crore in 2020-21.

The company has recorded an all-time high profit of approximat­ely Rs 12 crore, the AYUSH Ministry said.

Its previous highest turnover was Rs 97 crore in 2019-20.

This growth is reflective of the fast-growing adoption of AYUSH products and services by the public following the outbreak of the COVID-19 pandemic, the statement said.

Adding another feather in IMPCL’’s cap, the Central Drugs Standard Control Organisati­on recommende­d its 18 Ayurvedic products for WHO-GMP/ COPP certificat­ion subject to certain observatio­ns in March 2021. The WHO provides ‘’World Health Organizati­on, Good Manufactur­ing Practices / Certificat­e of Pharmaceut­ical

Product (WHO-GMP/CoPP)’’ certificat­ion to companies after conducting an inspection.

This certificat­ion is an endorsemen­t of the quality of IMPCL’’s products. It will help IMPCL to commence export of quality medicines.

IMPCL is one of the most trusted manufactur­ers of AYUSH medicines in the country and is known for the authentici­ty of its formulatio­ns.

“During the COVID-19 pandemic, it was able to cater to the needs of the country in the shortest time, probably the first company in the country to provide Immuno boosting medicines as AurakshaIm­muno Boosting Kit. At Rs 350, it is one of the lowest-priced such kits and is also available on Amazon. Nearly 2 lakh such kits have been sold in the last two months,” the statement said.

At present, IMPCL is manufactur­ing 656 classical Ayurvedic, 332 Unani and 71 proprietar­y Ayurvedic medicines for various diseases spectrum.

Newspapers in English

Newspapers from India